The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A novel biomarker panel examining response to adjuvant pancreatic cancer therapy in RTOG 9704.
Gregory M. Heestand
Consultant or Advisory Role - Bayer; Genomic Health
James Don Murphy
No relevant relationships to disclose
Jennifer Moughan
No relevant relationships to disclose
William Regine
No relevant relationships to disclose
Jia Luo
No relevant relationships to disclose
Madeline Sydney Graber
No relevant relationships to disclose
Pamela L. Kunz
Consultant or Advisory Role - Guardant Health
Stock Ownership - Guardant Health
Research Funding - AAA; Genentech; Lexicon; Merck; Sanofi
George A. Fisher
No relevant relationships to disclose
Chandan Guha
No relevant relationships to disclose
Bryan Lin
No relevant relationships to disclose
Rex B. Mowat
No relevant relationships to disclose
Rakesh Gaur
No relevant relationships to disclose
Mark K. Buyyounouski
No relevant relationships to disclose
Yuhchyau Chen
No relevant relationships to disclose
Daniel Tandel Chang
No relevant relationships to disclose
Albert Koong
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems